Stereotactic Radiosurgery May Be Best for Patients with Metastatic Brain Tumors

 

A recent study, published in The Journal of the American Medical Association, an international peer-reviewed medical journal, found that patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT).  For […]

 

Learn More

 

 

Metastatic Brain Tumor Patients Under 50 Show Improved Survival Rates with Stereotactic Radiosurgery

 

A recent study published in the International Journal of Radiation Oncology • Biology • Physics, the official journal of the American Society for Radiation Oncology (ASTRO), found that cancer patients with limited brain metastases who are under 50 years old could benefit from stereotactic radiosurgery (SRS) without whole brain radiation therapy (WBRT).  The study, “Phase […]

 

Learn More

 

 

Study: Stereotactic Radiosurgery Provides Improved Survival Rates for Metastatic Brain Tumor in Patients Under 50

 

According to a study recently published in the scientific journal of the American Society for Radiation Oncology (ASTRO), cancer patients with limited brain metastases who are under the age of 50 could benefit from receiving stereotactic radiosurgery (SRS) without whole brain radiation therapy (WBRT). The study analyzed patient data from the three largest randomized clinical […]

 

Learn More

 

 

Metastatic Cancer: How Does Cancer Spread?

 

The spread of cancer is often unpredictable. Though doctors may not be able to explain why or when cancer may spread, there are some indications that explain how cancer can spread. Most cancer cells travel through the blood or lymph nodes and once settled can reproduce, but where a cancer starts can play a role […]

 

Learn More

 

 

Illinois CyberKnife in the News: Researching Liver Metastases

 

In the January issue of DOTMed News, Illinois CyberKnife was among the CyberKnife® centers within the Alliance Oncology network to be featured for its innovative liver treatment protocol. Read our full feature here. This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help […]

 

Learn More

 

 

Presentation: How CyberKnife Treats Metastatic Tumors

 

At Illinois CyberKnife, we offer patients a nonsurgical treatment option for tumors that have spread from a primary location to another part of the body. View our presentation below to learn more about how CyberKnife treats metastatic tumors.

 

 

Learn More

 

 

Metastatic Breast Cancer: CyberKnife for Brain and Lung Lesions

 

The American Cancer Society estimates 9,230 cases of breast cancer will be diagnosed in Illinois this year, some of which may also be facing the spread of the disease to other organs. Patients with metastatic breast cancer often require a secondary or adjuvant treatment option for tumors that have spread to other parts of the […]

 

Learn More

 

 

Metastatic Liver Cancer Treatment

 

Many patients with liver cancer typically don’t show symptoms until the disease is beyond the primary stage and the cancer has advanced and spread to other parts of the body. When this occurs, tumors in secondary sites are known as metastatic liver cancer. The most common site for liver metastasis is the lungs. Illinois CyberKnife […]

 

Learn More

 

 

Illinois CyberKnife Treatment Protocol for Liver Cancer Metastases

 

Long considered incurable, liver metastasis treatment has typically focused on palliative care, but Illinois CyberKnife is working to change that. Overseen by Medical Director Dr. Arica Hirsch, Illinois CyberKnife’s clinical team developed a liver metastasis treatment protocol based on recent studies that show aggressive, local treatment can extend survival for certain patients. Illinois CyberKnife treats […]

 

Learn More

 

 

Benefits of SBRT for Metastatic Breast Cancer

 

Breast cancer is known universally to be one of the most common diagnoses for American women today, but what many may be unaware of is the potential for recurring or metastatic breast cancer. The American Cancer Society estimates that more than 200,000 women will be diagnosed with invasive breast cancer this year. In some cases, […]

 

Learn More